Antibody Drug Conjugates Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antibody Drug Conjugates Market to 2027 - Global Analysis and Forecasts By Technology (Cleavable Linker, Non-cleavable Linker); Application (Blood Cancer, Brain Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer) and Geography

Report Code: TIPRE00003494 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antibody Drug Conjugates (ADCs) are specifically to deliver cytotoxins to cancer cells with capacity to treat both solid tumors and hematologic cancers. With the help of a linker, an ADC is able to target and bind to cell-surface proteins found on cancer cells and release its cell-killing drugs. This property helps ADCs to selectively kill cancer cells and limit side effects for patients.

MARKET DYNAMICS
The antibody drug conjugates market is anticipated to grow in the forecast, owing to rising prevalence of cancer cases across the globe and growing geriatric population base. In addition, the presence of strong product offering in the pipeline by the players is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Antibody Drug Conjugates Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of antibody drug conjugates market with detailed market segmentation by technology, application and geography. The global antibody drug conjugates market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antibody drug conjugates market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global antibody drug conjugates market is segmented on the basis of technology and application Based on technology, the market is segmented as cleavable linker and non- cleavable linker. On the basis of application, the global antibody drug conjugates market is segmented into, blood cancer, brain cancer, breast cancer, ovarian cancer, lung cancer.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antibody drug conjugates market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibody drug conjugates market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antibody drug conjugates market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibody drug conjugates market in these regions.


MARKET PLAYERS

The reports cover key developments in the antibody drug conjugates market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from antibody drug conjugates market are anticipated to lucrative growth opportunities in the future with the rising demand for antibody drug conjugates market in the global market. Below mentioned is the list of few companies engaged in the antibody drug conjugates market.

The report also includes the profiles of key antibody drug conjugates market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AbbVie Inc.
  • Baxter Healthcare Corporation
  • CERBIOS - PHARMA SA
  • F. Hoffmann-La Roche Ltd
  • Lonza
  • Merck KGaA
  • Novasep
  • Pfizer Inc.
  • Piramal Group
  • Syngene
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibody Drug Conjugates Market - By Technology
1.3.2 Antibody Drug Conjugates Market - By Application
1.3.3 Antibody Drug Conjugates Market - By Region
1.3.3.1 By Country

2. KEY TAKEWAYS


3. RESEARCH METHODOLOGY


4. ANTIBODY DRUG CONJUGATES MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTIBODY DRUG CONJUGATES MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTIBODY DRUG CONJUGATES MARKET - GLOBAL MARKET ANALYSIS

6.1. ANTIBODY DRUG CONJUGATES - GLOBAL MARKET OVERVIEW
6.2. ANTIBODY DRUG CONJUGATES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIBODY DRUG CONJUGATES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY

7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. CLEAVABLE LINKER
7.3.1. Overview
7.3.2. Cleavable Linker Market Forecast and Analysis
7.4. NON-CLEAVABLE LINKER
7.4.1. Overview
7.4.2. Non-cleavable Linker Market Forecast and Analysis

8. ANTIBODY DRUG CONJUGATES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION

8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BLOOD CANCER
8.3.1. Overview
8.3.2. Blood Cancer Market Forecast and Analysis
8.4. BRAIN CANCER
8.4.1. Overview
8.4.2. Brain Cancer Market Forecast and Analysis
8.5. BREAST CANCER
8.5.1. Overview
8.5.2. Breast Cancer Market Forecast and Analysis
8.6. OVARIAN CANCER
8.6.1. Overview
8.6.2. Ovarian Cancer Market Forecast and Analysis
8.7. LUNG CANCER
8.7.1. Overview
8.7.2. Lung Cancer Market Forecast and Analysis

9. ANTIBODY DRUG CONJUGATES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Antibody Drug Conjugates Market Overview
9.1.2 North America Antibody Drug Conjugates Market Forecasts and Analysis
9.1.3 North America Antibody Drug Conjugates Market Forecasts and Analysis - By Technology
9.1.4 North America Antibody Drug Conjugates Market Forecasts and Analysis - By Application
9.1.5 North America Antibody Drug Conjugates Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antibody Drug Conjugates Market
9.1.5.1.1 United States Antibody Drug Conjugates Market by Technology
9.1.5.1.2 United States Antibody Drug Conjugates Market by Application
9.1.5.2 Canada Antibody Drug Conjugates Market
9.1.5.2.1 Canada Antibody Drug Conjugates Market by Technology
9.1.5.2.2 Canada Antibody Drug Conjugates Market by Application
9.1.5.3 Mexico Antibody Drug Conjugates Market
9.1.5.3.1 Mexico Antibody Drug Conjugates Market by Technology
9.1.5.3.2 Mexico Antibody Drug Conjugates Market by Application
9.2. EUROPE
9.2.1 Europe Antibody Drug Conjugates Market Overview
9.2.2 Europe Antibody Drug Conjugates Market Forecasts and Analysis
9.2.3 Europe Antibody Drug Conjugates Market Forecasts and Analysis - By Technology
9.2.4 Europe Antibody Drug Conjugates Market Forecasts and Analysis - By Application
9.2.5 Europe Antibody Drug Conjugates Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antibody Drug Conjugates Market
9.2.5.1.1 Germany Antibody Drug Conjugates Market by Technology
9.2.5.1.2 Germany Antibody Drug Conjugates Market by Application
9.2.5.2 France Antibody Drug Conjugates Market
9.2.5.2.1 France Antibody Drug Conjugates Market by Technology
9.2.5.2.2 France Antibody Drug Conjugates Market by Application
9.2.5.3 Italy Antibody Drug Conjugates Market
9.2.5.3.1 Italy Antibody Drug Conjugates Market by Technology
9.2.5.3.2 Italy Antibody Drug Conjugates Market by Application
9.2.5.4 Spain Antibody Drug Conjugates Market
9.2.5.4.1 Spain Antibody Drug Conjugates Market by Technology
9.2.5.4.2 Spain Antibody Drug Conjugates Market by Application
9.2.5.5 United Kingdom Antibody Drug Conjugates Market
9.2.5.5.1 United Kingdom Antibody Drug Conjugates Market by Technology
9.2.5.5.2 United Kingdom Antibody Drug Conjugates Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antibody Drug Conjugates Market Overview
9.3.2 Asia-Pacific Antibody Drug Conjugates Market Forecasts and Analysis
9.3.3 Asia-Pacific Antibody Drug Conjugates Market Forecasts and Analysis - By Technology
9.3.4 Asia-Pacific Antibody Drug Conjugates Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Antibody Drug Conjugates Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antibody Drug Conjugates Market
9.3.5.1.1 Australia Antibody Drug Conjugates Market by Technology
9.3.5.1.2 Australia Antibody Drug Conjugates Market by Application
9.3.5.2 China Antibody Drug Conjugates Market
9.3.5.2.1 China Antibody Drug Conjugates Market by Technology
9.3.5.2.2 China Antibody Drug Conjugates Market by Application
9.3.5.3 India Antibody Drug Conjugates Market
9.3.5.3.1 India Antibody Drug Conjugates Market by Technology
9.3.5.3.2 India Antibody Drug Conjugates Market by Application
9.3.5.4 Japan Antibody Drug Conjugates Market
9.3.5.4.1 Japan Antibody Drug Conjugates Market by Technology
9.3.5.4.2 Japan Antibody Drug Conjugates Market by Application
9.3.5.5 South Korea Antibody Drug Conjugates Market
9.3.5.5.1 South Korea Antibody Drug Conjugates Market by Technology
9.3.5.5.2 South Korea Antibody Drug Conjugates Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antibody Drug Conjugates Market Overview
9.4.2 Middle East and Africa Antibody Drug Conjugates Market Forecasts and Analysis
9.4.3 Middle East and Africa Antibody Drug Conjugates Market Forecasts and Analysis - By Technology
9.4.4 Middle East and Africa Antibody Drug Conjugates Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Antibody Drug Conjugates Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antibody Drug Conjugates Market
9.4.5.1.1 South Africa Antibody Drug Conjugates Market by Technology
9.4.5.1.2 South Africa Antibody Drug Conjugates Market by Application
9.4.5.2 Saudi Arabia Antibody Drug Conjugates Market
9.4.5.2.1 Saudi Arabia Antibody Drug Conjugates Market by Technology
9.4.5.2.2 Saudi Arabia Antibody Drug Conjugates Market by Application
9.4.5.3 U.A.E Antibody Drug Conjugates Market
9.4.5.3.1 U.A.E Antibody Drug Conjugates Market by Technology
9.4.5.3.2 U.A.E Antibody Drug Conjugates Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antibody Drug Conjugates Market Overview
9.5.2 South and Central America Antibody Drug Conjugates Market Forecasts and Analysis
9.5.3 South and Central America Antibody Drug Conjugates Market Forecasts and Analysis - By Technology
9.5.4 South and Central America Antibody Drug Conjugates Market Forecasts and Analysis - By Application
9.5.5 South and Central America Antibody Drug Conjugates Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antibody Drug Conjugates Market
9.5.5.1.1 Brazil Antibody Drug Conjugates Market by Technology
9.5.5.1.2 Brazil Antibody Drug Conjugates Market by Application
9.5.5.2 Argentina Antibody Drug Conjugates Market
9.5.5.2.1 Argentina Antibody Drug Conjugates Market by Technology
9.5.5.2.2 Argentina Antibody Drug Conjugates Market by Application

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTIBODY DRUG CONJUGATES MARKET, KEY COMPANY PROFILES

11.1. ABBVIE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAXTER HEALTHCARE CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CERBIOS - PHARMA SA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. F. HOFFMANN-LA ROCHE LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LONZA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK KGAA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVASEP
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PIRAMAL GROUP
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SYNGENE
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Baxter Healthcare Corporation
3. CERBIOS - PHARMA SA
4. F. Hoffmann-La Roche Ltd
5. Lonza
6. Merck KGaA
7. Novasep
8. Pfizer Inc.
9. Piramal Group
10. Syngene